Research note
GHK-Cu: Five Decades of Copper Peptide Science
GHK-Cu from its 1970s discovery to current skin and matrix research: the copper chemistry behind it, what studies have tested, and practical lab handling.
Among catalogue peptides, GHK-Cu has the longest research history of all. The tripeptide was pulled out of human plasma in the early 1970s, recognised as a copper(II) complex within a few years, and fifty years on it still generates publications in matrix biology and cosmetic science. It is also the clearest case of a molecule whose metal chemistry, more than its sequence, dictates almost every handling choice in the lab.
How it was discovered
The route to it was unusual. Work in the early 1970s asked why liver tissue from older donors behaved differently in culture from young tissue, and it traced the answer to a low-molecular-weight factor sitting in the albumin fraction of plasma. The factor proved to be Gly-His-Lys (glycyl-L-histidyl-L-lysine). Its histidine ring, free amino terminus and the backbone amide nitrogen between them form an almost ideal pocket for copper(II), and later work established that the active species in biology is the metal complex rather than the bare peptide.
Spec sheets therefore describe the complex — CAS 89030-95-5, with 403.93 Da for GHK-Cu versus roughly 340.4 Da for uncomplexed GHK. That 63 Da difference is the copper together with its coordination, and it is the number to check in an MS result to be sure the vial contains the complex rather than the metal-free peptide. Related terms: copper peptide, tripeptide.
The early literature also contains a finding that gets cited constantly — that GHK concentrations in plasma drop markedly from young adulthood to old age. Read it as a historical data point; it does not explain a mechanism.
Coordination chemistry drives handling
Copper(II) in the complex sits in an approximately square-planar geometry, bound by the imidazole nitrogen of histidine, the amino terminus and a deprotonated amide nitrogen of the backbone; solvent molecules and the lysine side chain fill the remaining space around it. Four practical rules follow, and together they explain most of the difficulties labs report with copper peptides.
- Watch the colour. Dissolved, the complex is intensely blue. Paling or a change of hue signals that the copper’s surroundings are different now — a free and genuinely useful quality check.
- pH needs more care than usual. Whether the amide nitrogen is deprotonated depends on pH, so the complex’s stability varies across the pH range, and strongly acidic media favour its breakdown.
- Chelators steal the metal. EDTA and similar agents, and certain buffer components, can strip the copper out. In cosmetic-science projects the compatibility of the formulation is a real variable of the experiment.
- Reductants change the copper. Ascorbate pushes Cu(II) toward Cu(I), which behaves as a different chemical species — an incompatibility well known from topical formulation studies.
Redox activity also runs the other way: once bound, copper can promote oxidation of sensitive residues in partners formulated alongside it, which is the key compatibility question for any blend containing a copper peptide.
What studies have looked at
The gene-expression studies deserve a caveat because they are frequently overstated. One widely cited analysis reported that exposing cultured cells to GHK shifted the expression of a large number of genes. That is a sound result about a cell-culture transcriptome, but it is not evidence of whole-body effects, and the two should not be conflated. For structure and mechanism, see our explainer on GHK-Cu.
The human data in this literature come from cosmetics: small controlled trials of GHK-Cu applied in topical products, which reported shifts in instrument-measured skin properties. They are genuine clinical studies, but brief, small and specific to the products tested, and nothing about other routes can be inferred from them.
How GHK-Cu compares with related molecules
The nearest analog is AHK-Cu (copper tripeptide-3, i.e. Ala-His-Lys bound to copper), which has been studied mainly around hair follicles rather than the dermal matrix. Swapping just the first residue changes the copper environment only a little, yet the biology diverges more than that small structural change would predict. Our side-by-side article GHK-Cu vs AHK-Cu covers this, and AHK-Cu is stocked as a separate product. Palmitoyl derivatives follow a third path: a fatty-acid chain is added to GHK to help formulation, not to change receptor-level behaviour.
Formats and practical lab points
Vials of GHK-Cu contain more material than most peptides in the range — 50, 100 or 200 mg — because its small molecular weight packs many moles into little mass. At 403.93 Da, 50 mg corresponds to roughly 124 µmol, about ten times the molecule count in 50 mg of a peptide weighing 4 kDa. Putting a copper tripeptide and a larger peptide side by side on a milligram basis is therefore a major error.
For topical work there are GHK-Cu face serum and a GHK-Cu cream; here the formulation factors listed above — pH, chelators, reducing agents, light reaching the product through its container — become the object of study rather than a footnote. See our article on topical peptides in cosmetic science for delivery questions, the copper peptide category for products, and the skin research overview for the wider class.
Why interest has endured
Fifty years of attention is remarkable for a molecule of three residues. The reason is its position at an intersection: it is simultaneously a peptide, a metal complex, a normal plasma component and a formulation ingredient supported by genuine human cosmetic data. Few other compounds in the catalogue combine all four. It also shows that the copper is not an accessory — remove it, and what is left is another molecule, with a separate literature of its own.
Questions
How do GHK and GHK-Cu differ?
GHK is the metal-free tripeptide glycyl-L-histidyl-L-lysine at about 340.4 Da. GHK-Cu is its copper(II) complex at 403.93 Da, in which copper is coordinated by the histidine ring, the amino terminus and a backbone amide nitrogen. The bulk of the published biology concerns the complex, so the copper belongs to the molecule and is not a contaminant.
What makes a GHK-Cu solution blue?
The colour arises from d-d transitions of the copper(II) ion in its near square-planar binding site. Because it depends on that geometry, fading or a hue change is an immediate, free indication that something — acidic pH, another chelator, a reductant — has disturbed the complex.
What formulation ingredients do not work with copper peptides?
Powerful chelators such as EDTA pull the copper away. Reducing agents like ascorbate shift it toward copper(I), which is a different species. Strong acid promotes dissociation. In multi-ingredient preparations, the copper can also catalyse oxidation of sensitive residues in the other components.
How strong is the human evidence for GHK-Cu?
It is confined to cosmetic research: small controlled studies of topical products that measured changes in skin parameters. These studies are genuine but limited in scale, length and how far they generalise, and they only apply to the specific formulations used. Mechanistic work has been done mostly in cells and animals.
Why do GHK-Cu vials come in 50 to 200 mg sizes?
Because each molecule weighs little. At 403.93 Da, 50 mg is roughly 124 µmol, far more molecules than a 4 kDa peptide delivers per equal weight. The bigger fill amounts reflect that molar difference, so any comparison with larger peptides belongs on a mole basis rather than in milligrams.
What distinguishes AHK-Cu from GHK-Cu?
AHK-Cu (copper tripeptide-3) carries alanine where GHK-Cu has glycine at position one. The structural change is small, but each has developed its own research focus: AHK-Cu appears mostly in hair-follicle work, while GHK-Cu leads the literature on the dermal matrix and wound repair.